Although the functions of ATIP associated with microtubules are totally unknown, microtubule-targeting agents including PPARγ inhibitors such as GW9662 are a very successful class of anti-cancer drugs with therapeutic benefits in both hematopoietic and solid tumors [52], [53]. The gene discussed is PPARG; the disease is cancer.